Zacks Research Predicts Stronger Earnings for Raymond James

Raymond James (NYSE:RJF) – Equities researchers at Zacks Research upped their Q1 2025 earnings per share estimates for shares of Raymond James in a research report issued to clients and investors on Wednesday, January 15th. Zacks Research analyst R. Department now anticipates that the financial services provider will post earnings per share of $2.72 for the quarter, up from their previous estimate of $2.69. The consensus estimate for Raymond James’ current full-year earnings is $10.99 per share. Zacks Research also issued estimates for Raymond James’ Q2 2025 earnings at $2.53 EPS, Q4 2025 earnings at $2.84 EPS, FY2025 earnings at $10.69 EPS, Q1 2026 earnings at $2.76 EPS, Q2 2026 earnings at $2.78 EPS, Q3 2026 earnings at $2.94 EPS, Q4 2026 earnings at $2.96 EPS, FY2026 earnings at $11.44 EPS, Q1 2027 earnings at $2.94 EPS and FY2027 earnings at $11.96 EPS.

Raymond James (NYSE:RJF) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.95 EPS for the quarter, topping analysts’ consensus estimates of $2.41 by $0.54. Raymond James had a return on equity of 19.30% and a net margin of 13.86%. The firm had revenue of $3.46 billion during the quarter, compared to analyst estimates of $3.32 billion. During the same period last year, the company earned $2.13 earnings per share. The company’s revenue was up 13.4% on a year-over-year basis.

RJF has been the topic of a number of other reports. UBS Group raised shares of Raymond James from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 6th. Morgan Stanley lifted their price objective on Raymond James from $132.00 to $145.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 29th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $166.00 price objective (up previously from $151.00) on shares of Raymond James in a report on Tuesday, January 7th. Wells Fargo & Company reduced their target price on Raymond James from $169.00 to $168.00 and set an “equal weight” rating on the stock in a report on Tuesday. Finally, Keefe, Bruyette & Woods upped their price target on Raymond James from $143.00 to $170.00 and gave the company a “market perform” rating in a research note on Friday, December 20th. Nine equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $156.09.

Raymond James Stock Up 2.2 %

Shares of NYSE:RJF opened at $164.89 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.02 and a quick ratio of 1.00. The stock has a market cap of $33.70 billion, a price-to-earnings ratio of 16.98, a P/E/G ratio of 0.89 and a beta of 1.02. The company has a 50 day moving average of $160.43 and a 200-day moving average of $135.96. Raymond James has a one year low of $104.24 and a one year high of $171.38.

Raymond James Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, January 16th. Investors of record on Thursday, January 2nd were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.21%. The ex-dividend date of this dividend was Thursday, January 2nd. This is a positive change from Raymond James’s previous quarterly dividend of $0.45. Raymond James’s dividend payout ratio is presently 20.60%.

Insider Activity at Raymond James

In other news, insider Tashtego S. Elwyn sold 10,000 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $159.47, for a total value of $1,594,700.00. Following the sale, the insider now directly owns 32,688 shares of the company’s stock, valued at approximately $5,212,755.36. This represents a 23.43 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Bella Loykhter Allaire sold 1,170 shares of Raymond James stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $169.43, for a total value of $198,233.10. Following the transaction, the insider now owns 80,421 shares of the company’s stock, valued at $13,625,730.03. The trade was a 1.43 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 64,621 shares of company stock valued at $10,729,488. Insiders own 0.54% of the company’s stock.

Institutional Trading of Raymond James

Hedge funds have recently made changes to their positions in the business. Wolff Wiese Magana LLC increased its holdings in shares of Raymond James by 3,960.0% during the 3rd quarter. Wolff Wiese Magana LLC now owns 203 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 198 shares during the last quarter. Quarry LP bought a new position in Raymond James during the second quarter worth $29,000. Future Financial Wealth Managment LLC acquired a new position in shares of Raymond James in the third quarter valued at $32,000. Gladius Capital Management LP bought a new position in shares of Raymond James in the third quarter valued at about $34,000. Finally, Peterson Financial Group Inc. acquired a new stake in shares of Raymond James during the 3rd quarter worth about $37,000. 83.83% of the stock is owned by institutional investors and hedge funds.

Raymond James Company Profile

Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.